BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28632924)

  • 1. Metabolomics as a Driver in Advancing Precision Medicine in Sepsis.
    Eckerle M; Ambroggio L; Puskarich MA; Winston B; Jones AE; Standiford TJ; Stringer KA
    Pharmacotherapy; 2017 Sep; 37(9):1023-1032. PubMed ID: 28632924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
    Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
    Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacometabolomics of l-carnitine treatment response phenotypes in patients with septic shock.
    Puskarich MA; Finkel MA; Karnovsky A; Jones AE; Trexel J; Harris BN; Stringer KA
    Ann Am Thorac Soc; 2015 Jan; 12(1):46-56. PubMed ID: 25496487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Power of proteomics and progress in precision medicine - 13th central and eastern European proteomic conference (CEEPC), Ustroń, Poland.
    Gadher SJ; Widlak P; Kovarova H
    Expert Rev Proteomics; 2020 May; 17(5):335-340. PubMed ID: 32510255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
    Mussap M; Loddo C; Fanni C; Fanos V
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of genomics to identify biomarkers and signaling molecules during severe sepsis.
    Douglas JJ; Roussel JA
    Minerva Anestesiol; 2016 Mar; 82(3):343-58. PubMed ID: 26091010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics and the Microbiome as Biomarkers in Sepsis.
    Lee J; Banerjee D
    Crit Care Clin; 2020 Jan; 36(1):105-113. PubMed ID: 31733672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging field of quantitative blood metabolomics for biomarker discovery in critical illnesses.
    Serkova NJ; Standiford TJ; Stringer KA
    Am J Respir Crit Care Med; 2011 Sep; 184(6):647-55. PubMed ID: 21680948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacometabonomics in humans: a new tool for personalized medicine.
    Everett JR
    Pharmacogenomics; 2015; 16(7):737-54. PubMed ID: 25929853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomics - A wide-open door to personalized treatment in chronic heart failure?
    Marcinkiewicz-Siemion M; Ciborowski M; Kretowski A; Musial WJ; Kaminski KA
    Int J Cardiol; 2016 Sep; 219():156-63. PubMed ID: 27323342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New frontiers in precision medicine for sepsis-induced immunoparalysis.
    Bruse N; Leijte GP; Pickkers P; Kox M
    Expert Rev Clin Immunol; 2019 Mar; 15(3):251-263. PubMed ID: 30572728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.
    Katsila T; Matsoukas MT; Patrinos GP; Kardamakis D
    OMICS; 2017 Aug; 21(8):429-439. PubMed ID: 28816643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharma-metabolomics in neonatology: is it a dream or a fact?
    Fanos V; Barberini L; Antonucci R; Atzori L
    Curr Pharm Des; 2012; 18(21):2996-3006. PubMed ID: 22564294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics as a Challenging Approach for Medicinal Chemistry and Personalized Medicine.
    Frédérich M; Pirotte B; Fillet M; de Tullio P
    J Med Chem; 2016 Oct; 59(19):8649-8666. PubMed ID: 27295417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Diagnosis of Sepsis: Is an Integrated Omics Approach the Way Forward?
    Langley RJ; Wong HR
    Mol Diagn Ther; 2017 Oct; 21(5):525-537. PubMed ID: 28624903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic consequences of sepsis-induced acute lung injury revealed by plasma ¹H-nuclear magnetic resonance quantitative metabolomics and computational analysis.
    Stringer KA; Serkova NJ; Karnovsky A; Guire K; Paine R; Standiford TJ
    Am J Physiol Lung Cell Mol Physiol; 2011 Jan; 300(1):L4-L11. PubMed ID: 20889676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond genomics: understanding exposotypes through metabolomics.
    Rattray NJW; Deziel NC; Wallach JD; Khan SA; Vasiliou V; Ioannidis JPA; Johnson CH
    Hum Genomics; 2018 Jan; 12(1):4. PubMed ID: 29373992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision medicine in pediatric sepsis.
    Atreya MR; Wong HR
    Curr Opin Pediatr; 2019 Jun; 31(3):322-327. PubMed ID: 31090572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacometabolomics of Asthma as a Road Map to Precision Medicine.
    Kelly RS; Cote MF; Begum S; Lasky-Su J
    Handb Exp Pharmacol; 2023; 277():247-273. PubMed ID: 36271166
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.